.In 2010, neuroscientist and former Eli Lilly investigation leader Steve Paul began a company that he hoped would spark a revolution in medication exploration created around a course of substances nicknamed neurosteroids that can help relax overactive brain circuits as well as ignite sleepy ones for a long list of psychological as well as nerve conditions.